期刊文献+

临床分离142株洋葱伯克霍尔德菌分布特征及耐药性分析 被引量:4

Distribution and drug resistance of 142 strains of Burkholderia cepacia isolated from clinical specimens
下载PDF
导出
摘要 目的了解南海区第三人民医院和佛山市第一人民医院洋葱伯克霍尔德菌医院感染的分布及耐药谱,为临床治疗及医院感染的控制提供依据。方法 2010年1月至2012年6月临床分离142株菌株,细菌鉴定和大多数药敏试验利用Vitek-compact全自动微生物分析仪,少数利用ATB Expression半自动微生物分析仪,个别药敏试验采用K-B法。药敏数据分析用WHONET5.4软件。结果痰液标本分离洋葱伯克霍尔德菌的阳性率最高,达到78.2%。洋葱伯克霍尔德菌对多种抗菌药物耐药,但对头孢吡肟、哌拉西林/他唑巴坦、左氧氟沙星、头孢他啶、复方磺胺甲噁唑敏感率较高,敏感率分别为83.1%、87.2%、87.3%、90.3%、90.9%。结论洋葱伯克霍尔德菌已成为医院分离的常见病原菌之一,医院应重视其耐药性监测,指导临床合理使用抗菌药物。 Objective To investigate the distribution and drug resistance of Burkholderia cepacia isolated from clinical specimens. Methods 142 strains were identified by Vitek-eompact. Antibiotics susceptivity tests were made by Vilek-compact or K B method. Drug resistance was analyzed by WHONETS. 4. Results The pathogenic bacteria were mainly isolated from sputum (78.20//oo). High levels of resistance to most antibiotics were found in Burkhotderia cepacia isolates. The sensitive rates of Burkholderia cepaeia to Cefepime, Piperacillin/tazobactam, Levofloxacin, Ceftazidime and Trimethoprim/sulfamethoxazole were 83. 1%, 87.2 %,87.3%, 90.3% and 90. 9%, respectively. Conclusion Burkholderia cepacia is one of the common pathogenic bacteria from clinical specimens. Hospitals should pay attention 1o the root cause of drug resistant bacteria and rational use of antimicrobial agent.
出处 《检验医学与临床》 CAS 2013年第7期773-774,共2页 Laboratory Medicine and Clinic
关键词 洋葱伯克霍尔德菌 临床分布 耐药性 Burkholderia .cepaeia ,clinical distribution drug resistance
  • 相关文献

参考文献8

二级参考文献59

共引文献44

同被引文献49

  • 1杨宝财,董胜峰,孙莉,黄照国,李鲜爱,崔幸琨,时东彦.2009-2013年临床分离洋葱伯克霍尔德菌耐药现状[J].医药导报,2015,34(S01):133-134. 被引量:4
  • 2Detsika MG,Corkill JE,Magalh(a)es M,et al.Molecular typing of,and distribution of genetic markers among,burkholderia cepacia complex isolates from Brazil[J].J Clin Microbiol,2003,41(9):4148-4153.
  • 3Dizbay M,Tunccan OG,Sezer BE,et al.Nosoccomial Burkholderia cepacia infections in a Turkish university hospital:a five-year surveillance[J].J Infect Dev Ctries,2009,3(4):273-277.
  • 4Vandamme P,Dawyndt P.Classification and identification of the Burkholderia cepacia complex:Past,present and future[J].Syst Appl Microbiol,2011,34(2):87-95.
  • 5Drevinek P,Mahenthiralingam E.Burkholderia cenocepacia in cystic fibrosis:epidemiology and molecular mechanisms of virulence[J].Clin Microbiol Intect,2010,16(7):821-830.
  • 6Romero-Gómez MP,Quiles Melero M1,Pe(n)a García P,et al.Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit[J].Infect Control Hosp Epidemiol,2008,29 (4):377-378.
  • 7Uvizl R,Hanulik V,Husickova V,et al.Hospital-acquired pneumonia in ICU patients[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2011,155(4):373-378.
  • 8Assaad W,Magalhāes M,Plesa M,et al.Identical Burkholderia cepacia complex strain types isolated from multiple patients attending a hospital in Brazil[J].J Med Microbiol,2006,55(Pt 2):247-249.
  • 9Pawar M,Mehta Y,Purohit A,et al.Resistance in gram negative bacilli in a cardiac intensive care unit in India:risk factors and outcome[J].Ann Card Anaesth,2008,11 (1):20-26.
  • 10Righi E,Girardis M,Marchegiano P,et al.Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex[J].J Hosp Infect,2013,85 (1):73-75.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部